Vault-13

683 Capital Management, LLC

NEW YORK, NY · CIK 1404574 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2012 · limited liability company

As an employer

$1.0bn reported value -8.0% vs Q1 2023
144positions
40.1%in top 10
14 new 25 added 28 reduced 141 sold out vs Q1 2023

Options: 2 call positions ($61.2m notional), 21 put positions ($302.7m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ENOVA INTL INC COM ENVA ENVA 1,450,000 $77.0m7.49% 7.49% ReducedShares held: Q3 2022 3.1m, Q4 2022 2.5m, Q1 2023 1.8m, Q2 2023 1.4m -390.0k -390,000 -21.2%
2 ERO COPPER CORP COM ERO ERO 3,000,000 $60.7m5.90% 5.90% ReducedShares held: Q3 2022 3.6m, Q4 2022 3.6m, Q1 2023 3.4m, Q2 2023 3.0m -425.0k -425,000 -12.4%
3 CAPITAL ONE FINL CORP COM COF COF 425,000 $46.5m4.52% 4.52% AddedShares held: Q3 2022 180.0k, Q4 2022 360.0k, Q1 2023 340.0k, Q2 2023 425.0k +85.0k +85,000 25.0%
4 BORGWARNER INC COM BWA BWA 943,000 $46.1m4.48% 4.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 550.0k, Q2 2023 943.0k +393.0k +393,000 71.5%
5 NOBLE CORP PLC ORD SHS A NE NE 825,000 $34.1m3.31% 3.31% UnchangedShares held: Q3 2022 0, Q4 2022 847.8k, Q1 2023 825.0k, Q2 2023 825.0k
6 OCCIDENTAL PETE CORP *W EXP 08/03/202 OXY.WS OXY.WS 854,600 $31.9m3.10% 3.10% UnchangedShares held: Q3 2022 854.6k, Q4 2022 854.6k, Q1 2023 854.6k, Q2 2023 854.6k
7 VISTRA CORP COM VST VST 1,170,000 $30.7m2.99% 2.99% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.2m
8 NEW YORK CMNTY BANCORP INC COM COM 2,600,000 $29.2m2.84% 2.84% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.6m
9 LENNAR CORP CL B LEN.B LEN.B 250,744 $28.3m2.75% 2.75% ReducedShares held: Q3 2022 76.9k, Q4 2022 299.4k, Q1 2023 299.4k, Q2 2023 250.7k -48.7k -48,656 -16.2%
10 IRSA INVERSIONES Y REP S A GLOBL DEP RCPT IRS IRS 3,470,486 $28.2m2.74% 2.74% ReducedShares held: Q3 2022 4.9m, Q4 2022 4.4m, Q1 2023 3.7m, Q2 2023 3.5m -229.5k -229,514 -6.2%
11 CAESARS ENTERTAINMENT INC NE COM CZR CZR 550,000 $28.0m2.73% 2.73% AddedShares held: Q3 2022 65.0k, Q4 2022 0, Q1 2023 350.0k, Q2 2023 550.0k +200.0k +200,000 57.1%
12 INSPIRED ENTMT INC COM INSE INSE 1,750,000 $25.7m2.50% 2.50% ReducedShares held: Q3 2022 2.4m, Q4 2022 2.1m, Q1 2023 1.9m, Q2 2023 1.8m -150.0k -150,000 -7.9%
13 CONCORD ACQUISITION CORP II COM CL A CNDA CNDA 2,475,000 $25.4m2.47% 2.47% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
14 HESS CORP COM HES HES 175,000 $23.8m2.31% 2.31% ReducedShares held: Q3 2022 317.6k, Q4 2022 240.0k, Q1 2023 230.0k, Q2 2023 175.0k -55.0k -55,000 -23.9%
15 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 814,000 $22.5m2.19% 2.19% AddedShares held: Q3 2022 0, Q4 2022 207.8k, Q1 2023 791.0k, Q2 2023 814.0k +23.0k +23,000 2.9%
16 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 6,031,000 $22.0m2.13% 2.13% AddedShares held: Q3 2022 7.6m, Q4 2022 6.0m, Q1 2023 6.0m, Q2 2023 6.0m +31.0k +31,000 0.5%
17 RYDER SYS INC COM R R 225,000 $19.1m1.86% 1.86% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 110.0k, Q2 2023 225.0k +115.0k +115,000 104.5%
18 HILTON GRAND VACATIONS INC COM HGV HGV 415,000 $18.9m1.83% 1.83% AddedShares held: Q3 2022 385.0k, Q4 2022 325.0k, Q1 2023 341.5k, Q2 2023 415.0k +73.5k +73,515 21.5%
19 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,287,500 $18.4m1.79% 1.79% ReducedShares held: Q3 2022 1.7m, Q4 2022 1.4m, Q1 2023 1.3m, Q2 2023 1.3m -38.0k -38,000 -2.9%
20 ALPHABET INC CAP STK CL A GOOGL GOOGL 150,000 $18.0m1.75% 1.75% ReducedShares held: Q3 2022 0, Q4 2022 40.0k, Q1 2023 203.0k, Q2 2023 150.0k -53.0k -53,000 -26.1%
21 ACTIVISION BLIZZARD INC COM ATVI ATVI 205,000 $17.3m1.68% 1.68% UnchangedShares held: Q3 2022 0, Q4 2022 90.0k, Q1 2023 205.0k, Q2 2023 205.0k
22 MEIRAGTX HLDGS PLC COM MGTX MGTX 2,457,609 $16.5m1.61% 1.61% AddedShares held: Q3 2022 1.7m, Q4 2022 1.7m, Q1 2023 1.7m, Q2 2023 2.5m +782.6k +782,609 46.7%
23 IMMATICS N.V SHS IMTX IMTX 1,350,000 $15.6m1.51% 1.51% AddedShares held: Q3 2022 1.4m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.4m +15.1k +15,063 1.1%
24 UNIQURE NV SHS QURE QURE 1,295,000 $14.8m1.44% 1.44% AddedShares held: Q3 2022 1.4m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.3m +202.0k +202,000 18.5%
25 CARDLYTICS INC COM COM 2,050,000 $13.0m1.26% 1.26% AddedShares held: Q3 2022 1.9m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 2.0m +225.0k +225,000 12.3%
26 CLEVELAND-CLIFFS INC NEW COM CLF CLF 751,000 $12.6m1.22% 1.22% NewShares held: Q3 2022 0, Q4 2022 600.0k, Q1 2023 0, Q2 2023 751.0k
27 VALARIS LTD CL A VAL VAL 200,000 $12.6m1.22% 1.22% AddedShares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 25.0k, Q2 2023 200.0k +175.0k +175,000 700.0%
28 WESTERN ALLIANCE BANCORP COM WAL WAL 300,000 $10.9m1.06% 1.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.0k
29 CRESUD S A C I F Y A SPONSORED ADR CRESY CRESY 1,399,200 $10.8m1.05% 1.05% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m -13.8k -13,767 -1.0%
30 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 300,000 $10.6m1.03% 1.03% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 150.0k, Q2 2023 300.0k +150.0k +150,000 100.0%
31 ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS CLASS A ORD SHS 1,000,000 $10.4m1.01% 1.01% UnchangedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
32 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,400,000 $9.9m0.96% 0.96% AddedShares held: Q3 2022 1.7m, Q4 2022 1.0m, Q1 2023 1.3m, Q2 2023 1.4m +75.0k +75,000 5.7%
33 BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 · principal BBIO 2.5 03.15.27 · principal BBIO 2.5 03.15.27 12,250,000 $9.6m0.93% 0.93% AddedPrincipal held: Q3 2022 0, Q4 2022 0, Q1 2023 3.0m, Q2 2023 12.2m +9.2m +9,250,000 308.3%
34 HAWKS ACQUISITION CORP CL A CL A 925,000 $9.5m0.92% 0.92% ReducedShares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 925.0k -1.1m -1,054,592 -53.3%
35 VIKING THERAPEUTICS INC COM VKTX VKTX 580,000 $9.4m0.91% 0.91% UnchangedShares held: Q3 2022 0, Q4 2022 29.0k, Q1 2023 580.0k, Q2 2023 580.0k
36 TECK RESOURCES LTD CL B TECK TECK 215,000 $9.1m0.88% 0.88% UnchangedShares held: Q3 2022 0, Q4 2022 135.0k, Q1 2023 215.0k, Q2 2023 215.0k
37 INFLARX NV COM IFRX IFRX 2,000,000 $8.9m0.87% 0.87% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.0m
38 RXO INC COMMON STOCK RXO RXO 355,000 $8.0m0.78% 0.78% AddedShares held: Q3 2022 0, Q4 2022 250.0k, Q1 2023 250.0k, Q2 2023 355.0k +105.0k +105,000 42.0%
39 TESLA INC COM TSLA TSLA 30,000 $7.9m0.76% 0.76% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 30.0k
40 ITEOS THERAPEUTICS INC COM ITOS ITOS 585,000 $7.7m0.75% 0.75% AddedShares held: Q3 2022 0, Q4 2022 150.0k, Q1 2023 480.0k, Q2 2023 585.0k +105.0k +105,000 21.9%
41 ZALATORIS ACQUISITION CORP COM CL A COM CL A 744,799 $7.7m0.75% 0.75% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 744.8k -740.0k -740,000 -49.8%
42 UPSTART HLDGS INC NOTE 0.250% 8/1 · principal UPST 0.25 08.15.26 · principal UPST 0.25 08.15.26 11,100,000 $7.6m0.74% 0.74% ReducedPrincipal held: Q3 2022 14.0m, Q4 2022 13.1m, Q1 2023 13.1m, Q2 2023 11.1m -2.0m -2,000,000 -15.3%
43 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 5,400,000 $7.1m0.69% 0.69% AddedShares held: Q3 2022 0, Q4 2022 125.0k, Q1 2023 2.0m, Q2 2023 5.4m +3.4m +3,400,000 170.0%
44 CITIGROUP INC COM NEW C C 150,000 $6.9m0.67% 0.67% AddedShares held: Q3 2022 0, Q4 2022 95.0k, Q1 2023 135.0k, Q2 2023 150.0k +15.0k +15,000 11.1%
45 CARDLYTICS INC NOTE 1.000% 9/1 · principal CDLX 1 09.15.25 · principal CDLX 1 09.15.25 11,025,000 $6.2m0.60% 0.60% UnchangedPrincipal held: Q3 2022 7.2m, Q4 2022 11.3m, Q1 2023 11.0m, Q2 2023 11.0m
46 CALLON PETE CO DEL COM CPE CPE 160,000 $5.6m0.55% 0.55% AddedShares held: Q3 2022 0, Q4 2022 86.0k, Q1 2023 125.0k, Q2 2023 160.0k +35.0k +35,000 28.0%
47 AFFIMED N V COM COM 9,000,000 $5.4m0.52% 0.52% UnchangedShares held: Q3 2022 8.3m, Q4 2022 9.0m, Q1 2023 9.0m, Q2 2023 9.0m
48 CRIXUS BH3 ACQUISITION CO CLASS A COM CLASS A COM 500,000 $5.2m0.50% 0.50% UnchangedShares held: Q3 2022 1.9m, Q4 2022 500.0k, Q1 2023 500.0k, Q2 2023 500.0k
49 XPERI INC COMMON STOCK XPER XPER 377,200 $5.0m0.48% 0.48% ReducedShares held: Q3 2022 0, Q4 2022 200.0k, Q1 2023 500.0k, Q2 2023 377.2k -122.8k -122,800 -24.6%
50 KNOT OFFSHORE PARTNERS LP COM UNITS KNOP KNOP 1,000,000 $4.9m0.48% 0.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 775.0k, Q2 2023 1.0m +225.0k +225,000 29.0%
51 CACTUS ACQUISITION CORP 1 LT CLASS A ORD CCTSF CCTSF 450,000 $4.8m0.46% 0.46% UnchangedShares held: Q3 2022 450.0k, Q4 2022 450.0k, Q1 2023 450.0k, Q2 2023 450.0k
52 GOSSAMER BIO INC NOTE 5.000% 6/0 · principal GOSS 5 06.01.27 · principal GOSS 5 06.01.27 15,145,000 $4.7m0.46% 0.46% NewPrincipal held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 15.1m
53 AXONPRIME INFRSTCTR AQSTN CO CLASS A COM CLASS A COM 441,137 $4.5m0.44% 0.44% UnchangedShares held: Q3 2022 441.1k, Q4 2022 441.1k, Q1 2023 441.1k, Q2 2023 441.1k
54 REALOGY GRP LLC/REALOGY CO NOTE 0.250% 6/1 · principal HOUS 0.25 06.15.26 · principal HOUS 0.25 06.15.26 6,000,000 $4.5m0.44% 0.44% UnchangedPrincipal held: Q3 2022 0, Q4 2022 0, Q1 2023 6.0m, Q2 2023 6.0m
55 INVIVYD INC COM IVVD IVVD 4,000,000 $4.2m0.41% 0.41% AddedShares held: Q3 2022 3.4m, Q4 2022 3.0m, Q1 2023 3.4m, Q2 2023 4.0m +600.0k +600,000 17.6%
56 CONCORD ACQUISITION CORP III COM CL A COM CL A 400,000 $4.2m0.40% 0.40% ReducedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 400.0k -2.1m -2,075,000 -83.8%
57 MATIV HOLDINGS INC COM MATV MATV 275,000 $4.2m0.40% 0.40% AddedShares held: Q3 2022 0, Q4 2022 300.0k, Q1 2023 87.3k, Q2 2023 275.0k +187.7k +187,654 214.8%
58 APELLIS PHARMACEUTICALS INC COM APLS APLS 44,300 $4.0m0.39% 0.39% ReducedShares held: Q3 2022 0, Q4 2022 175.0k, Q1 2023 160.0k, Q2 2023 44.3k -115.7k -115,700 -72.3%
59 TWO HARBORS INVENTMENT CORPO NOTE 6.250% 1/1 · principal TWO 6.25 01.15.26 · principal TWO 6.25 01.15.26 4,515,000 $4.0m0.39% 0.39% UnchangedPrincipal held: Q3 2022 0, Q4 2022 4.5m, Q1 2023 4.5m, Q2 2023 4.5m
60 FTAC ZEUS ACQUISITION COR CLASS A COM CLASS A COM 350,000 $3.6m0.35% 0.35% UnchangedShares held: Q3 2022 350.0k, Q4 2022 350.0k, Q1 2023 350.0k, Q2 2023 350.0k
61 XENIA HOTELS & RESORTS INC COM XHR XHR 293,742 $3.6m0.35% 0.35% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 293.7k
62 KEYARCH ACQUISITION CORP ORD SHS CL A ORD SHS CL A 342,452 $3.6m0.35% 0.35% UnchangedShares held: Q3 2022 342.5k, Q4 2022 342.5k, Q1 2023 342.5k, Q2 2023 342.5k
63 XERIS BIOPHARMA HOLDINGS INC NOTE 5.000% 7/1 · principal XERS 5 07.15.25 · principal XERS 5 07.15.25 2,950,000 $3.5m0.34% 0.34% UnchangedPrincipal held: Q3 2022 8.0m, Q4 2022 6.0m, Q1 2023 3.0m, Q2 2023 3.0m
64 SAREPTA THERAPEUTICS INC COM SRPT SRPT 30,600 $3.5m0.34% 0.34% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 30.6k
65 MAIDEN HOLDINGS LTD SHS MHLD MHLD 1,612,394 $3.4m0.33% 0.33% ReducedShares held: Q3 2022 4.4m, Q4 2022 2.5m, Q1 2023 2.2m, Q2 2023 1.6m -628.0k -628,006 -28.0%
66 CALIDI BIOTHERAPEUTICS INC COM NEW COM NEW 300,000 $3.1m0.31% 0.31% UnchangedShares held: Q3 2022 300.0k, Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k
67 NUVATION BIO INC COM CL A NUVB NUVB 1,575,000 $2.8m0.28% 0.28% ReducedShares held: Q3 2022 2.6m, Q4 2022 2.5m, Q1 2023 2.1m, Q2 2023 1.6m -525.0k -525,000 -25.0%
68 ALLY FINL INC COM ALLY ALLY 100,000 $2.7m0.26% 0.26% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k, Q2 2023 100.0k
69 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 475,000 $2.7m0.26% 0.26% ReducedShares held: Q3 2022 0, Q4 2022 27.3k, Q1 2023 530.3k, Q2 2023 475.0k -55.3k -55,310 -10.4%
70 FENNEC PHARMACEUTICALS INC COM FENC FENC 300,000 $2.6m0.26% 0.26% UnchangedShares held: Q3 2022 384.8k, Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k
71 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 3,750,000 $2.6m0.26% 0.26% ReducedShares held: Q3 2022 4.3m, Q4 2022 3.1m, Q1 2023 4.0m, Q2 2023 3.8m -200.0k -200,000 -5.1%
72 CONSILIUM ACQUISITN CORP I L CLASS A ORD SHS CLASS A ORD SHS 250,000 $2.6m0.26% 0.26% UnchangedShares held: Q3 2022 250.0k, Q4 2022 250.0k, Q1 2023 250.0k, Q2 2023 250.0k
73 OPY ACQUISITION CORP I COM CL A COM CL A 231,500 $2.4m0.23% 0.23% UnchangedShares held: Q3 2022 374.9k, Q4 2022 231.5k, Q1 2023 231.5k, Q2 2023 231.5k
74 GALAPAGOS NV SPON ADR LKFT LKFT 58,000 $2.4m0.23% 0.23% ReducedShares held: Q3 2022 122.8k, Q4 2022 101.8k, Q1 2023 94.0k, Q2 2023 58.0k -36.0k -35,971 -38.3%
75 GLOBALSTAR INC COM COM 2,000,000 $2.2m0.21% 0.21% UnchangedShares held: Q3 2022 1.3m, Q4 2022 912.2k, Q1 2023 2.0m, Q2 2023 2.0m
76 GALATA ACQUISITION CORP SHS CL A SHS CL A 200,000 $2.1m0.21% 0.21% UnchangedShares held: Q3 2022 200.0k, Q4 2022 200.0k, Q1 2023 200.0k, Q2 2023 200.0k
77 COINBASE GLOBAL INC NOTE 0.500% 6/0 · principal COIN 0.5 06.01.26 · principal COIN 0.5 06.01.26 2,250,000 $1.7m0.17% 0.17% UnchangedPrincipal held: Q3 2022 7.0m, Q4 2022 6.2m, Q1 2023 2.2m, Q2 2023 2.2m
78 ATARA BIOTHERAPEUTICS INC COM COM 1,000,000 $1.6m0.16% 0.16% NewShares held: Q3 2022 1.3m, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
79 PELOTON INTERACTIVE INC CL A COM PTON PTON 200,000 $1.5m0.15% 0.15% NewShares held: Q3 2022 250.0k, Q4 2022 0, Q1 2023 0, Q2 2023 200.0k
80 KAROOOOO LTD ORD SHS KARO KARO 64,000 $1.5m0.15% 0.15% UnchangedShares held: Q3 2022 64.0k, Q4 2022 64.0k, Q1 2023 64.0k, Q2 2023 64.0k
81 HERBALIFE NUTRITION LTD NOTE 2.625% 3/1 · principal HLF 2.625 03.15.24 · principal HLF 2.625 03.15.24 1,500,000 $1.5m0.14% 0.14% UnchangedPrincipal held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
82 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 420,000 $1.4m0.14% 0.14% ReducedShares held: Q3 2022 500.0k, Q4 2022 464.9k, Q1 2023 464.9k, Q2 2023 420.0k -44.9k -44,936 -9.7%
83 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 60,000 $1.3m0.12% 0.12% ReducedShares held: Q3 2022 1.1m, Q4 2022 570.0k, Q1 2023 390.0k, Q2 2023 60.0k -330.0k -330,000 -84.6%
84 CRESUD S A C I F Y A *W EXP 03/09/202 *W EXP 03/09/202 2,177,343 $1.2m0.12% 0.12% ReducedShares held: Q3 2022 2.7m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.2m -128.9k -128,900 -5.6%
85 RIGEL RESOURCE ACQ CORP CL A ORD SHS CL A ORD SHS 100,000 $1.1m0.10% 0.10% ReducedShares held: Q3 2022 350.0k, Q4 2022 350.0k, Q1 2023 350.0k, Q2 2023 100.0k -250.0k -250,000 -71.4%
86 LEAP THERAPEUTICS INC COM NEW CYPH CYPH 304,999 $954.6k0.09% 0.09% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 305.0k
87 PONCE FINANCIAL GROUP INC COMMON STOCK PDLB PDLB 106,137 $922.3k0.09% 0.09% AddedShares held: Q3 2022 21.1k, Q4 2022 18.6k, Q1 2023 90.0k, Q2 2023 106.1k +16.1k +16,137 17.9%
88 MODULAR MED INC COM NEW COM NEW 938,966 $920.1k0.09% 0.09% NewShares held: Q3 2022 114.4k, Q4 2022 0, Q1 2023 0, Q2 2023 939.0k
89 IRSA INVERSIONES Y REP S A *W EXP 05/12/202 *W EXP 05/12/202 1,599,075 $671.6k0.07% 0.07% AddedShares held: Q3 2022 1.7m, Q4 2022 1.7m, Q1 2023 1.6m, Q2 2023 1.6m +24.1k +24,064 1.5%
90 ZYMEWORKS INC COM ZYME ZYME 64,900 $560.7k0.05% 0.05% ReducedShares held: Q3 2022 0, Q4 2022 290.0k, Q1 2023 190.0k, Q2 2023 64.9k -125.1k -125,100 -65.8%
91 VACASA INC CLASS A COM CLASS A COM 805,876 $546.8k0.05% 0.05% ReducedShares held: Q3 2022 3.8m, Q4 2022 3.5m, Q1 2023 3.4m, Q2 2023 805.9k -2.5m -2,544,124 -75.9%
92 TIGO ENERGY INC *W EXP 05/23/202 *W EXP 05/23/202 90,050 $167.5k0.02% 0.02% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 90.0k
93 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 835,323 $138.2k0.01% 0.01% UnchangedShares held: Q3 2022 835.3k, Q4 2022 835.3k, Q1 2023 835.3k, Q2 2023 835.3k
94 INTL GNRL INSURANCE HLDNGS L *W EXP 03/17/202 *W EXP 03/17/202 221,611 $135.5k0.01% 0.01% ReducedShares held: Q3 2022 448.4k, Q4 2022 228.7k, Q1 2023 228.0k, Q2 2023 221.6k -6.4k -6,387 -2.8%
95 FREIGHTOS LTD *W EXP 99/99/999 CRGOW CRGOW 450,000 $106.7k0.01% 0.01% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 450.0k, Q2 2023 450.0k
96 FIRST LT ACQUISITION GROUP I *W EXP 03/14/202 CLDWW CLDWW 600,000 $78.0k0.01% 0.01% UnchangedShares held: Q3 2022 600.0k, Q4 2022 600.0k, Q1 2023 600.0k, Q2 2023 600.0k
97 TRAJECTORY ALPHA ACQUISITION *W EXP 99/99/999 *W EXP 99/99/999 742,500 $74.2k0.01% 0.01% UnchangedShares held: Q3 2022 742.5k, Q4 2022 742.5k, Q1 2023 742.5k, Q2 2023 742.5k
98 OPY ACQUISITION CORP I *W EXP 09/22/202 *W EXP 09/22/202 375,000 $56.2k0.01% 0.01% UnchangedShares held: Q3 2022 375.0k, Q4 2022 375.0k, Q1 2023 375.0k, Q2 2023 375.0k
99 GLOBAL TECHNOLGY ACQSTN CORP *W EXP 10/19/202 *W EXP 10/19/202 767,500 $53.3k0.01% 0.01% UnchangedShares held: Q3 2022 767.5k, Q4 2022 767.5k, Q1 2023 767.5k, Q2 2023 767.5k
100 KEYARCH ACQUISITION CORP RIGHT 01/24/2027 RIGHT 01/24/2027 350,000 $49.9k0.00% 0.00% UnchangedShares held: Q3 2022 350.0k, Q4 2022 350.0k, Q1 2023 350.0k, Q2 2023 350.0k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
LOGISTICS INNOVTN TECHNLGS C 1,994,266 $20.3m2.0m shares
PROVENTION BIO INC PRVB PRVB 825,000 $19.9m825.0k shares
JPMORGAN CHASE & CO JPM JPM 147,000 $19.2m147.0k shares
TIO TECH A 1,500,000 $15.3m1.5m shares
PANACEA ACQUISITION CORP II 1,480,000 $15.1m1.5m shares
BUILDERS FIRSTSOURCE INC BLDR BLDR 160,000 $14.2m160.0k shares
MASTERBRAND INC MBC MBC 1,750,000 $14.1m1.8m shares
TG THERAPEUTICS INC TGTX TGTX 775,000 $11.7m775.0k shares
GLOBAL TECHNOLGY ACQSTN CORP GTAC GTAC 1,035,000 $10.8m1.0m shares
BRIGHTHOUSE FINL INC BHF BHF 225,000 $9.9m225.0k shares
VALUENCE MERGER CORP I VMCAF VMCAF 700,000 $7.4m700.0k shares
ORION BIOTECH OPPORTUNTES CO 699,000 $7.2m699.0k shares
FOCUS IMPACT ACQUISITION COR 661,969 $6.9m662.0k shares
CONSOL ENERGY INC NEW 100,000 $5.8m100.0k shares
MICRON TECHNOLOGY INC MU MU 95,000 $5.7m95.0k shares
REATA PHARMACEUTICALS INC RETA RETA 60,000 $5.5m60.0k shares
TRINE II ACQUISITION CORP 499,300 $5.2m499.3k shares
GRAF ACQUISITION CORP IV 481,190 $4.9m481.2k shares
BANYAN ACQUISITION CORPORATI PNSTQ PNSTQ 450,000 $4.7m450.0k shares
CARVANA CO CVNA CVNA 475,000 $4.7m475.0k shares
CYMABAY THERAPEUTICS INC CBAY CBAY 500,000 $4.4m500.0k shares
LIV CAPITAL ACQUISITN CORP I 405,000 $4.2m405.0k shares
AETHERIUM ACQUISITION CORP 398,200 $4.2m398.2k shares
NABORS ENERGY TRANSITION COR 349,800 $3.7m349.8k shares
IAC INC PPLI PPLI 53,210 $2.7m53.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TESLA INC TSLA · Put TSLAPut 585,300 $153.2m585.3k shares Added
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 501,000 $45.6m501.0k shares New
ALPHABET INC GOOG · Put GOOGPut 200,000 $24.2m200.0k shares Added
CAPITAL ONE FINL CORP COF · Put COFPut 150,000 $16.4m150.0k shares Added
CARVANA CO CVNA · Call CVNACall 601,600 $15.6m601.6k shares Added
BANK AMERICA CORP BAC · Put BACPut 500,000 $14.3m500.0k shares Reduced
CARVANA CO CVNA · Put CVNAPut 430,000 $11.1m430.0k shares Added
COINBASE GLOBAL INC COIN · Put COINPut 125,000 $8.9m125.0k shares Unchanged
NOBLE CORP PLC NE · Put NEPut 200,000 $8.3m200.0k shares Unchanged
MADRIGAL PHARMACEUTICALS INC MDGL · Put MDGLPut 35,000 $8.1m35.0k shares Unchanged
PUBLIC STORAGE PSA · Put PSAPut 25,000 $7.3m25.0k shares Unchanged
MODERNA INC MRNA · Put MRNAPut 60,000 $7.3m60.0k shares Unchanged
HESS CORP HES · Put HESPut 50,000 $6.8m50.0k shares Reduced
GXO LOGISTICS INCORPORATED GXO · Put GXOPut 100,000 $6.3m100.0k shares Unchanged
LENNAR CORP LEN · Put LENPut 50,000 $6.3m50.0k shares Reduced
AMC ENTMT HLDGS INC Put Put 1,300,000 $5.7m1.3m shares Added
CAESARS ENTERTAINMENT INC NE CZR · Put CZRPut 100,000 $5.1m100.0k shares New
GE HEALTHCARE TECHNOLOGIES I GEHC · Put GEHCPut 50,000 $4.1m50.0k shares Reduced
VALARIS LTD VAL · Put VALPut 50,000 $3.1m50.0k shares Unchanged
RXO INC RXO · Put RXOPut 100,000 $2.3m100.0k shares Reduced
TECK RESOURCES LTD TECK · Put TECKPut 50,000 $2.1m50.0k shares New
SHOALS TECHNOLOGIES GROUP IN SHLS · Put SHLSPut 35,000 $894.6k35.0k shares Reduced
CLEVELAND-CLIFFS INC NEW CLF · Put CLFPut 52,800 $884.9k52.8k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GOSSAMER BIO INC GOSS · 13G · filed 2026-06-11 GOSS 10.0%≈ $8.2m +6.1 pts 13G 2026-06-11
MEREO BIOPHARMA GROUP PLC MREO · 13G · filed 2026-01-06 MREO 8.2% new 13G 2026-01-06
IN8BIO INC INAB · 13G · filed 2025-12-30 INAB 7.9%≈ $1.1m new 13G 2025-12-30
IMMUNIC INC 13G · filed 2026-02-17 5.9% -4.0 pts 13G 2026-02-17